Robert Pola

2.2k total citations
58 papers, 1.4k citations indexed

About

Robert Pola is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Robert Pola has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Biomaterials, 26 papers in Biomedical Engineering and 22 papers in Molecular Biology. Recurrent topics in Robert Pola's work include Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (21 papers) and RNA Interference and Gene Delivery (12 papers). Robert Pola is often cited by papers focused on Nanoparticle-Based Drug Delivery (30 papers), Nanoplatforms for cancer theranostics (21 papers) and RNA Interference and Gene Delivery (12 papers). Robert Pola collaborates with scholars based in Czechia, Germany and Netherlands. Robert Pola's co-authors include Michal Pechar, Karel Ulbrich, Tomáš Etrych, Twan Lammers, Gert Storm, Fabian Kießling, Felix Gremse, Benjamin Theek, Sijumon Kunjachan and Olga Janoušková and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Robert Pola

56 papers receiving 1.4k citations

Peers

Countries citing papers authored by Robert Pola

Since Specialization

Citations

This map shows the geographic impact of Robert Pola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pola more than expected).

Fields of papers citing papers by Robert Pola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Pola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pola. The network helps show where Robert Pola may publish in the future.

Co-authorship network of co-authors of Robert Pola

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Pola. A scholar is included among the top collaborators of Robert Pola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Pola. Robert Pola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nanomedicines for Delivery of Cytarabine: Effect of Carrier Structure and Spacer on the Anti-Lymphoma Efficacy 2025 ·Polymers ·Robert Pola, (unknown), Michal Pechar, Libor Kostka, Eva Pokorná, (unknown), Pavel Klener, Tomáš Etrych	0
2	Development of maleimide-modified poly(N-(2-hydroxylpropyl)methacrylamide) as a novel mucoadhesive polymer for nasal drug delivery 2025 ·European Polymer Journal ·Xiaoning Shan, Robert Pola, Daulet B. Kaldybekov, (unknown), Fhataheya Buang, Adrian C. Williams, Tomáš Etrych, Vitaliy V. Khutoryanskiy	0
3	RGD-coated polymeric microbubbles promote ultrasound-mediated drug delivery in an inflamed endothelium-pericyte co-culture model of the blood-brain barrier 2024 ·Drug Delivery and Translational Research ·(unknown), Junlin Chen, (unknown), Eva Miriam Buhl, (unknown), Robert Pola, Michal Pechar, Tomáš Etrych, Quim Peña, Anne Rix, Natascha Drude, Fabian Kießling, Twan Lammers, Jan‐Niklas May	3
4	Novel strategies for enhanced fluorescence visualization of glioblastoma tumors based on HPMA copolymers conjugated with tumor targeting and/or cell‐penetrating peptides 2024 ·SHILAP Revista de lepidopterología ·(unknown), Robert Pola, Marcela Filipová, Maxime Henry, Jean‐Luc Coll, Tomáš Etrych	5
5	Dual Thermo- and pH-Responsive Polymer Nanoparticle Assemblies for Potential Stimuli-Controlled Drug Delivery 2024 ·ACS Applied Bio Materials ·(unknown), Rafał Konefał, Robert Pola, (unknown), Volodymyr Lobaz, Miroslav Šlouf, Hynek Beneš, (unknown), (unknown), Marek Kovář, Tomáš Etrych, Richard Laga, Michal Pechar	5
6	Stimuli‐Responsive Polymer Nanoprobes Intended for Fluorescence‐Guided Surgery of Malignant Head‐and‐Neck Tumors and Metastases 2023 ·Advanced Healthcare Materials ·Robert Pola, (unknown), Michal Pechar, (unknown), (unknown), Jan Pankrác, Maxime Henry, (unknown), J Bouček, Luděk Šefc, Jean‐Luc Coll, Tomáš Etrych	3
7	Polymer-Antimicrobial Peptide Constructs with Tailored Drug-Release Behavior 2023 ·Pharmaceutics ·Robert Pola, (unknown), Jiří Trousil, (unknown), Michal Pechar, (unknown), Martin Studenovský, (unknown), Pavel Ulbrich, Barbora Vokatá, Tomáš Etrych	9
8	Radiosensitizing molybdenum iodide nanoclusters conjugated with a biocompatible N-(2-hydroxypropyl)methacrylamide copolymer: a step towards radiodynamic therapy 2023 ·Materials Advances ·Kaplan Kirakci, Robert Pola, (unknown), Michal Pechar, (unknown), Ivana Křížová, Jaroslav Zelenka, Tomáš Ruml, Tomáš Etrych, Kamil Lang	1
9	CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy 2023 ·Journal of Controlled Release ·Diana Möckel, Matthias Bartneck, Patricia M. Niemietz, (unknown), Josef Ehling, (unknown), Marek Weiler, Felix Gremse, Dirk Eulberg, Robert Pola, Michal Pechar, Tomáš Etrych, Gert Storm, Fabian Kießling, Frank Tacke, Twan Lammers	13
10	Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake 2023 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), (unknown), (unknown), (unknown), Robert Pola, Tomáš Etrych, Wiltrud Lederle, Twan Lammers, Felix Gremse, Fabian Kießling	4
11	The Transmission and Toxicity of Polymer-Bound Doxorubicin-Containing Exosomes Derived from Human Adenocarcinoma Celxdls 2022 ·Nanomedicine ·(unknown), (unknown), Marcela Filipová, (unknown), (unknown), Robert Pola, Eva Randárová, Tomáš Etrych, Olga Janoušková	2
12	Polymer nanomedicines with enzymatically triggered activation: A comparative study of in vitro and in vivo anti-cancer efficacy related to the spacer structure 2022 ·Nanomedicine Nanotechnology Biology and Medicine ·Michal Pechar, Robert Pola, Martin Studenovský, M Blahová, (unknown), (unknown), Marcela Filipová, (unknown), (unknown), Jun Fang, Tomáš Etrych	10
13	Functionalized hydrogel microparticles prepared by microfluidics and their interaction with tumour marker carbonic anhydrase IX 2020 ·Soft Matter ·(unknown), (unknown), (unknown), (unknown), Ondřej Kašpar, (unknown), Vlastimil Král, Michal Pechar, Robert Pola, Jérôme Bibette, Nicolas Brémond, František Štĕpánek, Viola Tokárová	6
14	Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo 2019 ·Biomaterials ·Can Ergen, Patricia M. Niemietz, Felix Heymann, (unknown), Felix Gremse, Robert Pola, Louis van Bloois, Gert Storm, Fabian Kießling, Christian Trautwein, Tom Luedde, Twan Lammers, Frank Tacke	20
15	Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles 2016 ·Biomaterials ·Can Ergen, Felix Heymann, Wa’el Al Rawashdeh, Felix Gremse, Matthias Bartneck, Ulf Panzer, Robert Pola, Michal Pechar, Gert Storm, Nicole Mohr, Matthias Barz, Rudolf Zentel, Fabian Kießling, Christian Trautwein, Twan Lammers, Frank Tacke	65
16	Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging 2014 ·Journal of Controlled Release ·Benjamin Theek, Felix Gremse, Sijumon Kunjachan, Stanley Fokong, Robert Pola, Michal Pechar, Roel Deckers, Gert Storm, Josef Ehling, Fabian Kießling, Twan Lammers	83
17	Multi-component Polymeric System for Tumour Cell-Specific Gene Delivery Using a Universal Bungarotoxin Linker 2010 ·Pharmaceutical Research ·Ralph A. Willemsen, Michal Pechar, Robert Carlisle, Erik van Schooten, Robert Pola, Amber Thompson, Leonard W. Seymour, Karel Ulbrich	16
18	HPMA-copolymer conjugates targeted to tumor endothelium using synthetic oligopeptides 2009 ·Journal of drug targeting ·Robert Pola, Martin Studenovský, Michal Pechar, Karel Ulbrich, Ondřej Hovorka, David Větvička, Blanka Řı́hová	16
19	Development of hydrophilic polymers to reduce the interaction of adenovirus type 5 with human blood components 2008 ·Human Gene Therapy ·Robert Carlisle, Vladimír Šubr, Robert Pola, Karel Ulbrich, (unknown)	1
20	Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers 2005 ·Journal of Controlled Release ·Twan Lammers, Rainer Kühnlein, Maria Kissel, Vladimír Šubr, Tomáš Etrych, Robert Pola, Michal Pechar, Karel Ulbrich, Gert Storm, Peter E. Huber, Peter Peschke	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact